<article article-type="case-report" dtd-version="1.4" xml:lang="en"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Case Rep Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">Case Rep Gastroenterol</journal-id><journal-id journal-id-type="pmc-domain-id">1184</journal-id><journal-id journal-id-type="pmc-domain">crg</journal-id><journal-id journal-id-type="publisher-id">CRG</journal-id><journal-title-group><journal-title>Case Reports in Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">1662-0631</issn><publisher><publisher-name>Karger Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12830003</article-id><article-id pub-id-type="pmcid-ver">PMC12830003.1</article-id><article-id pub-id-type="pmcaid">12830003</article-id><article-id pub-id-type="pmcaiid">12830003</article-id><article-id pub-id-type="pmid">41586403</article-id><article-id pub-id-type="doi">10.1159/000549935</article-id><article-id pub-id-type="publisher-id">549935</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Case and Review</subject></subj-group></article-categories><title-group><article-title>Hepatic Angiosarcoma Associated with Chronic Schistosomiasis in a Patient with Decompensated Cirrhosis: A Rare Case Report</article-title><alt-title alt-title-type="short">Hepatic Angiosarcoma in a Patient with Chronic Schistosomiasis and Cirrhosis</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="false" contrib-id-type="relnr">2810494</contrib-id><name name-style="western"><surname>Swaid</surname><given-names initials="T">Thaer</given-names></name><xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="false" contrib-id-type="relnr">2810495</contrib-id><name name-style="western"><surname>Kassab</surname><given-names initials="C">Carl</given-names></name><xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="false" contrib-id-type="relnr">2810496</contrib-id><name name-style="western"><surname>Ben Ghashir</surname><given-names initials="NS">Najla Saleh</given-names></name><xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="false" contrib-id-type="relnr">2810497</contrib-id><name name-style="western"><surname>Al Marzooqi</surname><given-names initials="SH">Saeed Husain</given-names></name><xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref></contrib><aff id="aff1">
<label>a</label>Department of Gastoenterology and Hepatology, Sheikh Shakhbout Medical City, <city>Abu Dhabi</city>, <country>United Arab Emirates</country></aff><aff id="aff2">
<label>b</label>Khalifa University College of Medicine and Health Sciences, <city>Abu Dhabi</city>, <country>United Arab Emirates</country></aff><aff id="aff3">
<label>c</label>Department of Clinical Pathology, Sheikh Shakhbout Medical City, <city>Abu Dhabi</city>, <country>United Arab Emirates</country></aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Thaer Swaid, <email>dr_t_haer@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>12</month><year>2025</year></pub-date><pub-date pub-type="collection"><season>Jan-Dec</season><year>2026</year></pub-date><volume>20</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">502957</issue-id><fpage>29</fpage><lpage>34</lpage><history><date date-type="received"><day>14</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>30</day><month>10</month><year>2025</year></date><date date-type="subscription-year"><year>2026</year></date></history><pub-history><event event-type="pmc-release"><date><day>24</day><month>12</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>24</day><month>01</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2026-01-26 15:25:12.620"><day>26</day><month>01</month><year>2026</year></date></event></pub-history><permissions><copyright-statement>© 2025 The Author(s). Published by S. Karger AG, Basel</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref content-type="ccbynclicense" specific-use="textmining" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (<ext-link ext-link-type="uri" xlink:href="https://karger.com/Services/OpenAccessLicense" xmlns:xlink="http://www.w3.org/1999/xlink">https://karger.com/Services/OpenAccessLicense</ext-link>). Usage and distribution for commercial purposes requires written permission.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="crg-2026-0020-0001-549935.pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/><abstract><title>Abstract</title><sec><title>Introduction</title><p>Hepatic angiosarcoma (HA) is a rare endothelial malignancy with poor prognosis. Chronic Schistosoma infection causes periportal fibrosis and portal hypertension, but has not been established as a risk factor for hepatic vascular tumors. We report a case of high-grade HA coexisting with chronic schistosomiasis in a patient presenting with acute decompensated cirrhosis.</p></sec><sec><title>Case Presentation</title><p>A 64-year-old Filipino woman with no known chemical exposures presented with progressive abdominal pain, jaundice, ascites, and hepatic encephalopathy. Doppler ultrasound initially suggested Budd-Chiari syndrome, later excluded on advanced imaging. MRI showed multifocal hepatic lesions, and CT demonstrated multiple intra-abdominal hematomas without active bleeding. Liver biopsy confirmed poorly differentiated HA (CD31+/CD34+) and revealed calcified Schistosoma eggs. Her course was complicated by hemorrhagic shock after biopsy and paracentesis, spontaneous bacterial peritonitis, acute kidney injury, and worsening hepatic encephalopathy. She died despite aggressive supportive care.</p></sec><sec><title>Conclusion</title><p>This case illustrates the diagnostic challenges and rapid progression of HA, especially in coagulopathic patients where biopsy carries significant risk. The coexistence of chronic schistosomiasis raises the possibility of parasitic inflammation contributing to hepatic vascular tumorigenesis. HA should be considered among unexplained hepatic masses with atypical imaging and clinical features.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Liver cirrhosis</kwd><kwd>Schistosomiasis</kwd><kwd>Hepatic angiosarcoma</kwd><kwd>Spontaneous bacterial peritonitis</kwd><kwd>Rare hepatic tumor</kwd></kwd-group><funding-group><funding-statement>This study was not supported by any sponsor or funder.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="1"/><ref-count count="6"/><page-count count="6"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC</meta-value></custom-meta><custom-meta><meta-name>accessibilitySummary</meta-name><meta-value>WCAG 2.1 Level AA</meta-value></custom-meta><custom-meta><meta-name>accessibility-pdf-ua-compliance</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="introduction"><title>Introduction</title><p>Hepatic angiosarcoma (HA) is a rare endothelial malignancy accounting for less than 1% of primary malignant liver tumors, with an estimated 200 cases diagnosed annually worldwide [<xref ref-type="bibr" rid="B1">1</xref>]. Prognosis is poor, with median survival of only a few months and a 1-year survival rate of 12.8% [<xref ref-type="bibr" rid="B2">2</xref>]. Risk factors include exposure to vinyl chloride monomer, arsenic, thorium dioxide, and ionizing radiation, although approximately 75% of cases have no identifiable cause [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>]. Currently, there is no evidence to suggest an association between angiosarcoma and parasitic infections such as schistosomiasis.</p><p>Schistosomiasis, caused by trematode blood flukes of the genus <italic toggle="yes">Schistosoma</italic>, affects over 200 million people worldwide. Chronic infection can result in periportal fibrosis, portal hypertension, and cirrhosis [<xref ref-type="bibr" rid="B3">3</xref>]. Long-standing inflammation is known to increase hepatocellular carcinoma risk, but only one previous case report has described HA coinciding with schistosomiasis [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>HA may mimic other hepatic malignancies such as hepatocellular carcinoma, cholangiocarcinoma, or even benign vascular lesions like hemangiomas [<xref ref-type="bibr" rid="B5">5</xref>]. Given its rarity, nonspecific presentation, and overlapping imaging features, diagnosis often requires a high index of suspicion and histopathological confirmation.</p><p>This case report has been prepared in accordance with the CARE reporting guidelines. The completed CARE Checklist is provided in the online supplementary material (for all online suppl. material, see <ext-link ext-link-type="doi" xlink:href="10.1159/000549935" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/10.1159/000549935</ext-link>).</p></sec><sec id="s2" sec-type="case report"><title>Case Report</title><p>A 64-year-old woman of Filipino origin presented with 1.5 months of worsening epigastric pain and fatigue. Two weeks later, she re-presented with persistent abdominal pain, new-onset jaundice, abdominal distention, lower limb swelling, pruritus, dark urine, nausea, and poor oral intake. She declined admission at that time. Two months later, she returned with further deterioration, including altered mental status and reduced responsiveness.</p><p>She had no significant past medical history, no known exposure to hepatotoxic chemicals, and no family history of liver disease. Social history was notable for occasional alcohol consumption and no use of tobacco, illicit drugs, or herbal supplements. On examination, she was icteric with tense abdominal distention and shifting dullness consistent with ascites, as well as bilateral symmetric lower limb edema.</p><sec id="s2-1"><title>Differential Diagnosis</title><p>Initial differentials included decompensated cirrhosis from any chronic liver disease, Budd-Chiari syndrome, hepatocellular carcinoma, metastatic liver disease, viral hepatitis, drug-induced liver injury, and autoimmune hepatitis.</p></sec><sec id="s2-2"><title>Laboratory Results</title><sec id="s2-2-1"><title>Imaging</title><p>Initial abdominal ultrasound with Doppler demonstrated features of cirrhosis, portal hypertension, mild ascites, and reduced hepatic vein flow, raising suspicion for Budd-Chiari syndrome. Subsequent MRI showed a multinodular cirrhotic liver with multifocal lesions suspicious for malignancy (shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>). Abdominal CT was performed to further characterize the lesions and assess for possible intervention. This revealed multiple intra-abdominal hematomas (largest 10 cm) without active extravasation (shown in <xref ref-type="fig" rid="F2">Fig. 2</xref>), explaining her progressive anemia and hemodynamic instability.</p><fig id="F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>MRI abdomen (axial view) demonstrating a multinodular cirrhotic liver with irregular contour and multiple variable-sized lesions scattered throughout the parenchyma, findings highly suspicious for malignancy.</p></caption><graphic orientation="portrait" position="float" xlink:href="crg-2026-0020-0001-549935_F01.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"><alt-text>Axial MRI of the abdomen showing a multinodular cirrhotic liver with irregular contour and multiple lesions, suggestive of hepatic malignancy.</alt-text></graphic></fig><fig id="F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>Abdominal CT (axial), both arterial (L) and venous (R) phase, showing features of hepatic cirrhosis with multiple focal variable enhancing lesions + multiple collaterals in the splenorenal region. Presence of large (11.2 × 10.5 × 10 cm) hematoma traversing from liver hilum/caudate lobe to the splenic hilum.</p></caption><graphic orientation="portrait" position="float" xlink:href="crg-2026-0020-0001-549935_F02.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"><alt-text>Axial CT images in arterial and venous phases demonstrating cirrhotic liver with focal enhancing lesions, collaterals in the splenorenal region, and a large intra-abdominal hematoma.</alt-text></graphic></fig></sec><sec id="s2-2-2"><title>Histopathology</title><p>Given the uncertain diagnosis and progressive course, image-guided liver biopsy was performed after careful risk assessment. Microscopy demonstrated a poorly differentiated malignant neoplasm of spindle cells forming irregular vascular channels. Immunohistochemistry revealed diffuse CD31 and CD34 positivity, confirming HA. Multiple calcified <italic toggle="yes">Schistosoma</italic> eggs were also present, indicating chronic schistosomiasis (shown in <xref ref-type="fig" rid="F3">Fig. 3</xref>, <xref ref-type="fig" rid="F4">4</xref>).</p><fig id="F3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>H&amp;E stained sections (×20) showing liver parenchyma with angiosarcoma (black arrowhead) and calcified Schistosoma eggs (encircled) (L), and demonstrating a malignant, mitotically active spindle cell neoplasm with vasoformative differentiation (R).</p></caption><graphic orientation="portrait" position="float" xlink:href="crg-2026-0020-0001-549935_F03.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"><alt-text>Histopathology slide at 20x magnification showing spindle cell angiosarcoma within liver tissue and calcified Schistosoma eggs.</alt-text></graphic></fig><fig id="F4" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p>Photomicrographs (×2) showing CD31 (L) and CD34 (R) immunostain strongly and diffusely positive on tumor cells.</p></caption><graphic orientation="portrait" position="float" xlink:href="crg-2026-0020-0001-549935_F04.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"><alt-text>Immunohistochemistry images showing diffuse CD31 and CD34 positivity in tumor cells, consistent with endothelial origin</alt-text></graphic></fig></sec><sec id="s2-2-3"><title>Clinical Course and Outcome</title><p>Following biopsy and therapeutic paracentesis, the patient developed worsening anemia and hemodynamic instability consistent with intra-abdominal bleeding. <xref ref-type="table" rid="T1">Table 1</xref> shows ascitic fluid obtained during paracentesis that demonstrated features consistent with spontaneous bacterial peritonitis, with WBC 1,200 × 10<sup>6</sup>/L (78% neutrophils), protein 32 g/L, albumin 19 g/L, and glucose 5.2 mmol/L; fluid culture grew <italic toggle="yes">Escherichia coli</italic>. She was initiated on intravenous piperacillin-tazobactam. Despite antimicrobial therapy and transfusion support, she progressed to hemorrhagic shock, respiratory failure, and worsening hepatic encephalopathy. Surgical intervention was deemed futile given her critical condition and poor prognosis. She was admitted to the intensive care unit with hepatic encephalopathy several days later and subsequently developed cardiopulmonary arrest and died. The adverse event was considered likely related to post-procedural hemorrhage in the context of coagulopathy and fragile tumor vasculature.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Key laboratory results and ascitic fluid analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Test category</th><th colspan="1" rowspan="1">Parameter</th><th colspan="1" rowspan="1">Result/findings</th></tr></thead><tbody><tr><td colspan="1" rowspan="3">Hematology</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">13.0 g/dL</td></tr><tr><td colspan="1" rowspan="1">WBC (peripheral)</td><td colspan="1" rowspan="1">8.5 ×10<sup>9</sup>/L</td></tr><tr><td colspan="1" rowspan="1">Platelets</td><td colspan="1" rowspan="1">130 ×10<sup>9</sup>/L</td></tr><tr><td colspan="1" rowspan="1">Coagulation</td><td colspan="1" rowspan="1">INR</td><td colspan="1" rowspan="1">1.69 → 2.7 (peak)</td></tr><tr><td colspan="1" rowspan="4">Liver function</td><td colspan="1" rowspan="1">Total bilirubin</td><td colspan="1" rowspan="1">24.0 mg/dL → 52.3 mg/dL (peak)</td></tr><tr><td colspan="1" rowspan="1">AST</td><td colspan="1" rowspan="1">145 U/L</td></tr><tr><td colspan="1" rowspan="1">ALT</td><td colspan="1" rowspan="1">67 U/L</td></tr><tr><td colspan="1" rowspan="1">Albumin (serum)</td><td colspan="1" rowspan="1">1.4 g/dL</td></tr><tr><td colspan="1" rowspan="1">Renal function</td><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">1.98 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Viral hepatitis panel</td><td colspan="1" rowspan="1">Hepatitis A, B, C, E</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="8">Ascitic fluid</td><td colspan="1" rowspan="1">WBC</td><td colspan="1" rowspan="1">1,200 ×10<sup>6</sup>/L</td></tr><tr><td colspan="1" rowspan="1">RBC</td><td colspan="1" rowspan="1">300 ×10<sup>6</sup>/L</td></tr><tr><td colspan="1" rowspan="1">Polymorphs</td><td colspan="1" rowspan="1">83%</td></tr><tr><td colspan="1" rowspan="1">Neutrophils</td><td colspan="1" rowspan="1">78%</td></tr><tr><td colspan="1" rowspan="1">Albumin (fluid)</td><td colspan="1" rowspan="1">19 g/L</td></tr><tr><td colspan="1" rowspan="1">Protein (fluid)</td><td colspan="1" rowspan="1">32 g/L</td></tr><tr><td colspan="1" rowspan="1">Glucose (fluid)</td><td colspan="1" rowspan="1">5.2 mmol/L</td></tr><tr><td colspan="1" rowspan="1">Culture</td><td colspan="1" rowspan="1">
<italic toggle="yes">Escherichia coli</italic> (positive)</td></tr><tr><td colspan="1" rowspan="1">Interpretation</td><td colspan="1" rowspan="1">​</td><td colspan="1" rowspan="1">Consistent with spontaneous bacterial peritonitis (SBP) due to elevated neutrophils and positive culture</td></tr></tbody></table></table-wrap></sec></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>This case highlights several diagnostic and therapeutic challenges in HA. Clinically, HA presents with vague symptoms such as abdominal pain, fatigue, and weight loss, and often mimics other hepatic lesions [<xref ref-type="bibr" rid="B3">3</xref>]. Imaging findings are heterogeneous; Doppler may show altered hepatic vein flow (as in this case), prompting consideration of Budd-Chiari syndrome, but absence of thrombosis on further imaging helps exclude it.</p><p>Histopathology remains the gold standard, with tumor cells typically expressing endothelial markers such as CD31, CD34, and factor VIII-related antigen [<xref ref-type="bibr" rid="B3">3</xref>]. Prognosis is extremely poor, and most patients are ineligible for surgical resection due to multifocal disease. Chemotherapy and radiotherapy have limited efficacy.</p><p>Schistosomiasis causes chronic granulomatous inflammation around deposited eggs, leading to periportal fibrosis, portal hypertension, and cirrhosis. The persistent inflammatory state generates reactive oxygen species and may induce mutations in tumor suppressor genes (e.g., p53) and promote vascular endothelial growth factor-mediated angiogenesis [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B6">6</xref>]. Although no causal relationship between schistosomiasis and HA has been established, the coexistence of both conditions in this and a previously reported case [<xref ref-type="bibr" rid="B6">6</xref>] suggests a possible pathogenic link worthy of further study.</p></sec><sec id="s4" sec-type="conclusion"><title>Conclusion</title><p>This case describes the rare coexistence of HA and chronic schistosomiasis in a patient with decompensated cirrhosis. HA should be considered in the differential diagnosis of unexplained hepatic masses, especially when imaging and clinical presentation are atypical. Early biopsy is essential for diagnosis, though procedural risks are significant in coagulopathic patients. While schistosomiasis is not an established risk factor for HA, cases like this prompt further investigation into the potential role of chronic parasitic inflammation in hepatic vascular tumorigenesis.</p></sec><sec id="s5" sec-type="statement of ethics"><title>Statement of Ethics</title><p>Ethical approval was not required for this case report in accordance with institutional policies. The Sheikh Shakhbout Medical City (SSMC) Research Ethics Committee, Abu Dhabi, UAE, reviewed the case and confirmed that it was exempt from formal ethics approval. Written informed consent for publication of the patient’s clinical details and accompanying images was obtained from the patient’s next-of-kin.</p></sec><sec id="s6" sec-type="COI-statement"><title>Conflict of Interest Statement</title><p>The authors have no conflicts of interest to declare.</p></sec><sec id="s7" sec-type="funding sources"><title>Funding Sources</title><p>This study was not supported by any sponsor or funder.</p></sec><sec id="s8" sec-type="author contributions"><title>Author Contributions</title><p>T.S. conceived the case report, coordinated clinical data collection, and supervised the project. C.K. performed the literature review, drafted the initial manuscript, and contributed to data interpretation. N.S.B.G. assisted with data acquisition, imaging review, and critical revision of the manuscript. S.H.A.M. contributed to clinical management of the patient, verified the clinical details, and provided substantial manuscript revisions. All authors reviewed and approved the final manuscript.</p></sec></body><back><sec id="s12" sec-type="data-availability"><title>Data Availability Statement</title><p>All data generated or analyzed during this study are included in this article and its online supplementary files. Further inquiries can be directed to the corresponding author.</p></sec><sec id="s18" sec-type="supplementary-material"><label>Supplementary Material</label><supplementary-material content-type="local-data" id="SD1" orientation="portrait" position="float"><media id="d67e457" orientation="portrait" position="anchor" xlink:href="Supplementary_material-Suppl.1-s1.doc" xmlns:xlink="http://www.w3.org/1999/xlink"/></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Chaudhary</surname>
<given-names>P</given-names>
</string-name>, <string-name name-style="western"><surname>Bhadana</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Ahuja</surname><given-names>A</given-names></string-name></person-group>. <article-title>Primary hepatic angiosarcoma</article-title>. <source>Eur J Surg Oncol</source>. <year>2015</year>;<volume>41</volume>(<issue>9</issue>):<fpage>1137</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">26008857</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.ejso.2015.04.022</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Frenette</surname>
<given-names>C</given-names>
</string-name>, <string-name name-style="western"><surname>Mendiratta-Lala</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Salgia</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Sauer</surname><given-names>BG</given-names></string-name>, <string-name name-style="western"><surname>Pillai</surname><given-names>A</given-names></string-name></person-group>. <article-title>ACG clinical guideline: focal liver lesions</article-title>. <source>Am J Gastroenterol</source>. <year>2024</year>;<volume>119</volume>(<issue>7</issue>):<fpage>1235</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">38958301</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.14309/ajg.0000000000002857</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Colley</surname>
<given-names>DG</given-names>
</string-name>, <string-name name-style="western"><surname>Bustinduy</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Secor</surname><given-names>WE</given-names></string-name>, <string-name name-style="western"><surname>King</surname><given-names>CH</given-names></string-name></person-group>. <article-title>Human schistosomiasis</article-title>. <source>Lancet</source>. <year>2014</year>;<volume>383</volume>(<issue>9936</issue>):<fpage>2253</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">24698483</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/S0140-6736(13)61949-2</pub-id><pub-id pub-id-type="pmcid">PMC4672382</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Wang</surname>
<given-names>ZS</given-names>
</string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>WX</given-names></string-name>, <string-name name-style="western"><surname>Xiong</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Zhan</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name></person-group>. <article-title>Spontaneous ruptured primary hepatic angiosarcoma coincident with Schistosoma Japonica liver fibrosis</article-title>. <source>Hepatol Res</source>. <year>2007</year>;<volume>37</volume>(<issue>7</issue>):<fpage>572</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">17540001</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1111/j.1872-034X.2007.00067.x</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Yasir</surname>
<given-names>S</given-names>
</string-name>, <string-name name-style="western"><surname>Torbenson</surname><given-names>MS</given-names></string-name></person-group>. <article-title>Angiosarcoma of the liver: clinicopathologic features and morphologic patterns</article-title>. <source>Am J Surg Pathol</source>. <year>2019</year>;<volume>43</volume>(<issue>5</issue>):<fpage>581</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">30986799</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1097/PAS.0000000000001228</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="western">
<surname>Yu</surname>
<given-names>Y</given-names>
</string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lei</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>R</given-names></string-name>, <etal/></person-group>. <article-title>Schistosome eggs stimulate reactive oxygen species production to enhance M2 macrophage differentiation and promote hepatic pathology in schistosomiasis</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2021</year>;<volume>15</volume>(<issue>8</issue>):<fpage>e0009696</fpage>.<pub-id pub-id-type="pmid">34398890</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1371/journal.pntd.0009696</pub-id><pub-id pub-id-type="pmcid">PMC8389433</pub-id></mixed-citation></ref></ref-list></back></article>